Factors associated with cognitive impairment in patients with atrial fibrillation: A systematic review and meta-analysis.

ABSTRACT

BACKGROUND: Atrial fibrillation (AF) is associated with an increased risk of cognitive impairment. Therefore, exploring factors which may be associated with cognitive impairment is important. Correspondingly, this study aimed to systematically evaluate factors associated with cognitive impairment in AF patients by synthesizing relevant evidence. METHODS: A database search of the PubMed, Embase, Cochrane Library, Web of Science, CBM, CNKI, Wanfang, and VIP databases was conducted from inception until December 21, 2023. The effect size was expressed as a combined odds ratio (OR) and 95 % confidence interval (95 % CI). The heterogeneity was qualitatively analyzed by Cochran's Q test and quantified by the I2 statistic. RESULTS: A total of 7,128 studies were identified from the 8 databases, and 39 studies of 3,491,423 participants were included. A meta-analysis was performed on 19 influencing factors. Advanced age (OR=1.38, 95 % CI 1.11-1.71), female sex (OR=2.19, 95 % CI 1.18-4.06), smoking (OR=2.44, 95 % CI 1.24-4.80), hypertension (OR=1.61, 95 % CI 1.27-2.03), diabetes (OR=1.42, 95 % CI 1.20-1.67), and hearing impairment (OR=1.37, 95 % CI 1.05-1.81) were risk factors for cognitive impairment. A higher education level (OR=0.57, 95 % CI 0.46-0.72), oral anticoagulants (OR=0.61, 95 % CI 0.48-0.78), novel oral anticoagulants (OR=0.63, 95 % CI 0.54-0.73), warfarin (OR=0.55, 95 % CI 0.39-0.79), novel oral anticoagulants relative to warfarin (OR=0.88, 95 % CI 0.81-0.97), catheter ablation (OR=0.74, 95 % CI 0.58-0.94) and exercise (OR=0.66, 95 % CI 0.61-0.72) were protective factors for cognitive impairment. CONCLUSIONS: Age, sex, education level, smoking, exercise, hypertension, diabetes, hearing impairment, anticoagulation therapy, and catheter ablation were associated with cognitive impairment in AF patients.